The DOI matches its Crossref record; 123 of the 123 references it cites were found in a registry or an index.
Parkinson’s Disease in Women and Men: What’s the Difference?
Open accessAbstract
Increasing evidence points to biological sex as an important factor in the development and phenotypical expression of Parkinson’s disease (PD). Risk of developing PD is twice as high in men than women, but women have a higher mortality rate and faster progression of the disease. Moreover, motor and nonmotor symptoms, response to treatments and disease risk factors differ between women and men. Altogether, sex-related differences in PD support the idea that disease development might involve distinct pathogenic mechanisms (or the same mechanism but in a different way) in male and female patients. This review summarizes the most recent knowledge concerning differences between women and men in PD clinical features, risk factors, response to treatments and mechanisms underlying the disease pathophysiology. Unraveling how the pathology differently affect the two sexes might allow the development of tailored interventions and the design of innovative programs that meet the distinct needs of men and women, improving patient care.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Impulse Control Disorders in Parkinson Disease: A Cross-Sectional Study of 3090 Patients
Weintraub, D., Koester, J., Potenza, M. N., Siderowf, A. D., Stacy, M., Voon, V., Whetteckey, J., Wunderlich, G. R., & Lang, A. E. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.65 · Cited by 1,487
Gender differences in Parkinson's disease
Haaxma, C. A., Bloem, B. R., Borm, G. F., Oyen, W. J. G., Leenders, K. L., Eshuis, S., Booij, J., Dluzen, D. E., & Horstink, M. W. I. M. (2007) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.103788 · Cited by 741
Parkinson disease: from pathology to molecular disease mechanisms
Dexter, D. T., & Jenner, P. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.01.018 · Cited by 707
Sex differences in microglial colonization of the developing rat brain
Schwarz, J. M., Sholar, P. W., & Bilbo, S. D. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07630.x · Cited by 672
Sex-specific features of microglia from adult mice
Villa, A., Gelosa, P., Castiglioni, L., Cimino, M., Rizzi, N., Pepe, G., Lolli, F., Marcello, E., Sironi, L., Vegeto, E., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.05.048 · Cited by 651
The Incidence of Parkinson's Disease: A Systematic Review and Meta-Analysis
Hirsch, L., Jette, N., Frolkis, A., Steeves, T., & Pringsheim, T. (2016) · Neuroepidemiology · doi:10.1159/000445751 · Cited by 571
Parkinson’s disease and parkinsonism in a longitudinal study: Two-fold higher incidence in men
Baldereschi, M., Di Carlo, A., Rocca, W. A., Vanni, P., Maggi, S., Perissinotto, E., Grigoletto, F., Amaducci, L., & Inzitari, D. (2000) · Neurology · doi:10.1212/wnl.55.9.1358 · Cited by 526
Microglia Are Essential to Masculinization of Brain and Behavior
Lenz, K. M., Nugent, B. M., Haliyur, R., & McCarthy, M. M. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.1268-12.2013 · Cited by 526
Hormone-replacement therapy: current thinking
Lobo, R. A. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.164 · Cited by 484
Fabbrini, G., Brotchie, J. M., Grandas, F., Nomoto, M., & Goetz, C. G. (2007) · Movement Disorders · doi:10.1002/mds.21475 · Cited by 464
Hanamsagar, R., Alter, M. D., Block, C. S., Sullivan, H., Bolton, J. L., & Bilbo, S. D. (2017) · Glia · doi:10.1002/glia.23176 · Cited by 384
Urate as a Predictor of the Rate of Clinical Decline in Parkinson Disease
Ascherio, A. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.247 · Cited by 354
When Does Parkinson Disease Start?
Savica, R., Rocca, W. A., & Ahlskog, J. E. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.135 · Cited by 312
Neurologist care in Parkinson disease: A utilization, outcomes, and survival study
Willis, A. W., Schootman, M., Evanoff, B. A., Perlmutter, J. S., & Racette, B. A. (2011) · Neurology · doi:10.1212/wnl.0b013e31822c9123 · Cited by 303
Serum uric acid levels and the risk of Parkinson disease
de Lau, L. M. L., Koudstaal, P. J., Hofman, A., & Breteler, M. M. B. (2005) · Annals of Neurology · doi:10.1002/ana.20663 · Cited by 301
Hanamsagar, R., Alter, M. D., Block, C. S., Sullivan, H., Bolton, J. L., & Bilbo, S. D. (2018) · Glia · doi:10.1002/glia.23277 · Cited by 295
Szewczyk-Krolikowski, K., Tomlinson, P., Nithi, K., Wade-Martins, R., Talbot, K., Ben-Shlomo, Y., & Hu, M. T. M. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2013.09.025 · Cited by 294
Prevalence and determinants of rapid eye movement sleep behavior disorder in the general population
Haba-Rubio, J., Frauscher, B., Marques-Vidal, P., Toriel, J., Tobback, N., Andries, D., Preisig, M., Vollenweider, P., Postuma, R., & Heinzer, R. (2018) · Sleep · doi:10.1093/sleep/zsx197 · Cited by 285
Gender-related differences in the burden of non-motor symptoms in Parkinson’s disease
Martinez-Martin, P., Falup Pecurariu, C., Odin, P., Hilten, J. J., Antonini, A., Rojo-Abuin, J. M., Borges, V., Trenkwalder, C., Aarsland, D., Brooks, D. J., et al. (2012) · Journal of Neurology · doi:10.1007/s00415-011-6392-3 · Cited by 282
Palmer, A. L., & Ousman, S. S. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00337 · Cited by 250
Selective estrogen receptor modulators: tissue specificity and clinical utility
Arnott, J., Martinkovich, S., Planey, S. L., & Shah, D. (2014) · Clinical Interventions in Aging · doi:10.2147/cia.s66690 · Cited by 234
Effects of gender on nigral gene expression and parkinson disease
Cantuti-Castelvetri, I., Keller-McGandy, C., Bouzou, B., Asteris, G., Clark, T. W., Frosch, M. P., & Standaert, D. G. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.02.009 · Cited by 234
The relationship between glucocerebrosidase mutations and Parkinson disease
Migdalska‐Richards, A., & Schapira, A. H. V. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13385 · Cited by 231
Stress, depression and Parkinson's disease
Hemmerle, A. M., Herman, J. P., & Seroogy, K. B. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2011.09.035 · Cited by 225
Gender differences in Parkinson’s disease: A clinical perspective
Georgiev, D., Hamberg, K., Hariz, M., Forsgren, L., & Hariz, G.-M. (2017) · Acta Neurologica Scandinavica · doi:10.1111/ane.12796 · Cited by 220
Yaffe, K., Krueger, K., Cummings, S. R., Blackwell, T., Henderson, V. W., Sarkar, S., Ensrud, K., & Grady, D. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.4.683 · Cited by 212
Estrogen improves motor disability in parkinsonian postmenopausal women with motor fluctuations
Tsang, K.-L., Ho, S.-L., & Lo, S.-K. (2000) · Neurology · doi:10.1212/wnl.54.12.2292 · Cited by 203
Stool Immune Profiles Evince Gastrointestinal Inflammation in Parkinson's Disease
Houser, M. C., Chang, J., Factor, S. A., Molho, E. S., Zabetian, C. P., Hill‐Burns, E. M., Payami, H., Hertzberg, V. S., & Tansey, M. G. (2018) · Movement Disorders · doi:10.1002/mds.27326 · Cited by 199
Sex differences in the inflammatory response of primary astrocytes to lipopolysaccharide
Santos-Galindo, M., Acaz-Fonseca, E., Bellini, M. J., & Garcia-Segura, L. M. (2011) · Biology of Sex Differences · doi:10.1186/2042-6410-2-7 · Cited by 191
Gender differences in motor and non-motor symptoms among Sardinian patients with Parkinson's disease
Solla, P., Cannas, A., Ibba, F. C., Loi, F., Corona, M., Orofino, G., Marrosu, M. G., & Marrosu, F. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.07.026 · Cited by 178
LRRK2 pathobiology in Parkinson's disease
Martin, I., Kim, J. W., Dawson, V. L., & Dawson, T. M. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12949 · Cited by 167
Gender and the Parkinson’s disease phenotype
Baba, Y., Putzke, J. D., Whaley, N. R., Wszołek, Z. K., & Uitti, R. J. (2005) · Journal of Neurology · doi:10.1007/s00415-005-0835-7 · Cited by 155
Šimunović, F., Yi, M., Wang, Y., Stephens, R. M., & Sonntag, K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008856 · Cited by 153
Rafferty, M. R., Schmidt, P. N., Luo, S., Li, K., Marras, C., Davis, T. L., Guttman, M., Cubillos, F., Simuni, T., & on behalf of all NPF-QII Investigators (2016) · Journal of Parkinson s Disease · doi:10.3233/jpd-160912 · Cited by 153
Sex differences in progression to mild cognitive impairment and dementia in Parkinson's disease
Cholerton, B., Johnson, C. O., Fish, B. E., Quinn, J. F., Chung, K. A., Peterson‐Hiller, A. L., Rosenthal, L. S., Dawson, T. M., Albert, M., Hu, S., et al. (2018) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2018.02.007 · Cited by 152
Gaignard, P., Savouroux, S., Liere, P., Pianos, A., Thérond, P., Schumacher, M., Slama, A., & Guennoun, R. (2015) · Endocrinology · doi:10.1210/en.2014-1913 · Cited by 150
A detailed clinical study of pain in 1957 participants with early/moderate Parkinson's disease
Silverdale, M., Kobylecki, C., Kass‐Iliyya, L., Martínez‐Martín, P., Lawton, M., Cotterill, S., Chaudhuri, К. R., Morris, H. R., Baig, F., Williams, N. M., et al. (2018) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2018.06.001 · Cited by 149
Higher serum cholesterol and decreased Parkinson's disease risk: A statin‐free cohort study
Rozani, V., Gurevich, T., Giladi, N., El‐Ad, B., Tsamir, J., Hemo, B., & Peretz, C. (2018) · Movement Disorders · doi:10.1002/mds.27413 · Cited by 128
Sex disparities in access to caregiving in Parkinson disease
Dahodwala, N. A., Shah, K., He, Y., Wu, S. S., Schmidt, P. N., Cubillos, F., & Willis, A. W. (2017) · Neurology · doi:10.1212/wnl.0000000000004764 · Cited by 127
l -Dopa-induced adverse effects in PD and dopamine transporter gene polymorphism
Kaiser, R., Höfer, A., Grapengiesser, A., Gasser, T., Kupsch, A. R., Roots, I., & Brockmöller, J. (2003) · Neurology · doi:10.1212/01.wnl.0000068009.32067.a1 · Cited by 126
Potential sex differences in nonmotor symptoms in early drug-naive Parkinson disease
Liu, R., Umbach, D. M., Peddada, S. D., Xu, Z., Tröster, A. I., Huang, X., & Chen, H. (2015) · Neurology · doi:10.1212/wnl.0000000000001609 · Cited by 121
Life span pigmentation changes of the substantia nigra detected by neuromelanin‐sensitive MRI
Xing, Y., Sapuan, A. H., Dineen, R. A., & Auer, D. P. (2018) · Movement Disorders · doi:10.1002/mds.27502 · Cited by 109
Functional neurological disorders in Parkinson disease
Wissel, B. D., Dwivedi, A. K., Merola, A., Chin, D., Jacob, C., Duker, A. P., Vaughan, J. E., Lovera, L., LaFaver, K., Levy, A., et al. (2018) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2017-317378 · Cited by 106
Sex-Related Abnormalities in Substantia Nigra Lipids in Parkinson’s Disease
Seyfried, T. N., Choi, H. S., Chevalier, A. C., Hogan, D. V., Akgoc, Z., & Schneider, J. S. (2018) · ASN NEURO · doi:10.1177/1759091418781889 · Cited by 104
Parkinson disease with and without Dementia: A prevalence study and future projections
Savica, R., Grossardt, B. R., Rocca, W. A., & Bower, J. H. (2018) · Movement Disorders · doi:10.1002/mds.27277 · Cited by 98
Colombo, D., Abbruzzese, G., Antonini, A., Barone, P., Bellia, G., Franconi, F., Simoni, L., Attar, M., Zagni, E., Haggiag, S., et al. (2015) · The Scientific World JOURNAL · doi:10.1155/2015/787451 · Cited by 88
Association study of dopamine D2, D3 receptor gene polymorphisms with motor fluctuations in PD
Wang, J., Liu, Z.-L., & Chen, B. (2001) · Neurology · doi:10.1212/wnl.56.12.1757 · Cited by 86
Yazğan, Y., & Nazıroğlu, M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0232-5 · Cited by 85
Paba, S., Frau, R., Godar, S. C., et al. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211795049589 · Cited by 83
Influence of Estrogen Modulation on Glia Activation in a Murine Model of Parkinson's Disease
Siani, F., Greco, R., Levandis, G., Ghezzi, C., Daviddi, F., Demartini, C., Vegeto, E., Armentero, M., & Blandini, F. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00306 · Cited by 83
Self-citationYun, J., Yeo, I. J., Hwang, C. J., Choi, D., Im, H.-S., Kim, J. Y., Choi, W. R., Jung, M. H., Han, S., & Hong, J. T. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.05.013 · Cited by 83
Alpha galactosidase A activity in Parkinson's disease
Alcalay, R. N., Wolf, P., Levy, O. A., Kang, U. J., Waters, C., Fahn, S., Ford, B., Kuo, S., Vanegas, N., Shah, H., et al. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.01.012 · Cited by 81
Gender differences in REM sleep behavior disorder: a clinical and polysomnographic study in China
Zhou, J., Zhang, J., Li, Y., Du, L., Li, Z., Lei, F., Wing, Y. K., Kushida, C. A., Zhou, D., & Tang, X. (2015) · Sleep Medicine · doi:10.1016/j.sleep.2014.10.020 · Cited by 79
A Microglial Signature Directing Human Aging and Neurodegeneration-Related Gene Networks
Mukherjee, S., Klaus, C. R., Pricop‐Jeckstadt, M., Miller, J. A., & Struebing, F. L. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00002 · Cited by 78
Luchetti, S., Bossers, K., Frajese, G. V., & Swaab, D. F. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00396.x · Cited by 76
Nakano, M., Imamura, H., Sasaoka, N., Yamamoto, M., Uemura, N., Shudo, T., Fuchigami, T., Takahashi, R., & Kakizuka, A. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.07.024 · Cited by 76
Predictive clinical factors for penetration and aspiration in Parkinson's disease
Nienstedt, J. C., Bihler, M., Niessen, A. C., Plaetke, R., Pötter‐Nerger, M., Gerloff, C. P., Buhmann, C., & Pflug, C. (2018) · Neurogastroenterology & Motility · doi:10.1111/nmo.13524 · Cited by 76
Evidence for Gender Differences in Cognition, Emotion and Quality of Life in Parkinson’s Disease?
Helle, J. (2014) · Aging and Disease · doi:10.14336/ad.2014.050063 · Cited by 74
Picillo, M., Erro, R., Amboni, M., Longo, K., Vitale, C., Moccia, M., Pierro, A., Scannapieco, S., Santangelo, G., Spina, E., et al. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.04.023 · Cited by 72
Sampaio, T. F., dos Santos, E. U. D., de Lima, G. D. C., dos Anjos, R. S. G., da Silva, R. C., Asano, A. G., Asano, N. M. J., Crovella, S., & de Souza, P. R. E. (2018) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1096 · Cited by 70
Plasma Urate and Parkinson's Disease in Women
O'Reilly, E. J., Gao, X., Weisskopf, M. G., Chen, H., Schwarzschild, M. A., Spiegelman, D. L., & Ascherio, A. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwq195 · Cited by 69
Marín, R., & Díaz, M. L. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00128 · Cited by 67
Lifetime exposure to estrogens and Parkinson's disease in California teachers
Gatto, N. M., Deapen, D., Stoyanoff, S., Pinder, R., Narayan, S., Bordelon, Y. M., & Ritz, B. R. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.08.003 · Cited by 65
Evidence for gender differences in cognition, emotion and quality of life in Parkinson's disease?
Heller, J., Dogan, I., Schulz, J., & Reetz, K. (2014) · Aging and Disease · doi:10.14366/ad.2014.050063 · Cited by 65
Physical Activity in Early Parkinson Disease
Mantri, S., Fullard, M. E., Duda, J. E., & Morley, J. F. (2018) · Journal of Parkinson s Disease · doi:10.3233/jpd-171218 · Cited by 65
Kim, H. J., Magranè, J., Starkov, A. A., & Manfredi, G. (2012) · Brain · doi:10.1093/brain/aws208 · Cited by 64
Cullity, E. R., Madsen, H. B., Perry, C. J., & Kim, J. H. (2018) · The Journal of Comparative Neurology · doi:10.1002/cne.24574 · Cited by 64
Age and sex-related changes in rat brain mitochondrial oxidative status
Guevara, R., Gianotti, M., Oliver, J., & Roca, P. (2011) · Experimental Gerontology · doi:10.1016/j.exger.2011.08.003 · Cited by 63 · cited 1×
“Generally, lower oxidative stress and damage have been observed in brain mitochondria from female rats compared with males, independently of age and estrus cycle [115, 118].”
BackgroundHealthy Brain Aging Modifies Microglial Calcium Signaling In Vivo
Olmedillas, M., Asavapanumas, N., Uzcategui, N. L., & Garaschuk, O. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030589 · Cited by 63
Relative survival in patients with dementia with Lewy bodies and Parkinson’s disease dementia
Larsson, V., Torisson, G., & Londos, E. (2018) · PLoS ONE · doi:10.1371/journal.pone.0202044 · Cited by 61
The impact of Parkinson disease on patients’ sexuality and relationship
Buhmann, C., Dogac, S., Vettorazzi, E., Hidding, U., Gerloff, C. P., & Jürgens, T. P. (2016) · Journal of Neural Transmission · doi:10.1007/s00702-016-1649-8 · Cited by 60
Levodopa pharmacokinetics and dyskinesias: are there sex-related differences?
Martinelli, P., Contin, M., Scaglione, C. L. M., Riva, R., Albani, F., & Baruzzi, A. (2003) · Neurological Sciences · doi:10.1007/s10072-003-0125-z · Cited by 59
Song, Z., Yang, H., Peckham, E. M., & Becker, J. B. (2019) · eNeuro · doi:10.1523/eneuro.0446-18.2019 · Cited by 59
Sex Differences in the Pharmacokinetics of Levodopa in Elderly Patients With Parkinson Disease
Kumagai, T., Nagayama, H., Ota, T., Nishiyama, Y., Mishina, M., & Ueda, M. (2014) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000051 · Cited by 56
Gender differences in quality of life following subthalamic stimulation for Parkinson's disease
Hariz, G., Limousin, P. D., Zrinzo, L. U., Tripoliti, E., Avilés-Olmos, I., Jahanshahi, M., Hamberg, K., & Foltynie, T. (2013) · Acta Neurologica Scandinavica · doi:10.1111/ane.12127 · Cited by 54
Hormonal Replacement Therapy in Women With Parkinson Disease and Levodopa-Induced Dyskinesia
Nicoletti, A. S. Q., Arabia, G., Pugliese, P., Nicoletti, G., Torchia, G., Condino, F., Morgante, L., Quattrone, A., & Zappia, M. (2007) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e318050c9f9 · Cited by 53
GPER Agonist G1 Attenuates Neuroinflammation and Dopaminergic Neurodegeneration in Parkinson Disease
Guan, J., Yang, B., Fan, Y., & Zhang, J. (2017) · Neuroimmunomodulation · doi:10.1159/000478908 · Cited by 53
Conway, S. M., Puttick, D. J., Russell, S. E., Potter, D. N., Roitman, M. F., & Chartoff, E. H. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.12.002 · Cited by 53
Clinical Markers of Anxiety Subtypes in Parkinson Disease
Broen, M. P. G., Leentjens, A. F. G., Hinkle, J. T., Moonen, A. J. H., Kuijf, M. L., Fischer, N. M., Perepezko, K. M., Bakker, A., & Pontone, G. M. (2018) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988718757369 · Cited by 50
Association of Parkinson’s disease with industry sectors: a French nationwide incidence study
Vlaar, T., Kab, S., Schwaab, Y., Fréry, N., Elbaz, A., & Moisan, F. (2018) · European Journal of Epidemiology · doi:10.1007/s10654-018-0399-3 · Cited by 50
Cognitive Profiles and Hub Vulnerability in Parkinson's Disease
Lin, S., Baumeister, T. R., Garg, S., & McKeown, M. J. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00482 · Cited by 50
Aging modulates microglia phenotypes in neuroinflammation of MPTP-PD mice
Yao, K., & Zhao, Y. (2018) · Experimental Gerontology · doi:10.1016/j.exger.2018.07.010 · Cited by 49
Richter, D., Bartig, D., Muhlack, S., Hartelt, E., Scherbaum, R., Katsanos, A. H., Müller, T. H., Jost, W. H., Ebersbach, G., Gold, R., et al. (2019) · Cells · doi:10.3390/cells8020151 · Cited by 49
Bhattacharjee, S. (2018) · Neurology India · doi:10.4103/0028-3886.237019 · Cited by 49
Goudreau, J. L., Maraganore, D. M., Farrer, M. J., Lesnick, T. G., Singleton, A., Bower, J. H., Hardy, J., & Rocca, W. A. (2002) · Movement Disorders · doi:10.1002/mds.10268 · Cited by 47
Mitochondrial function in human brains is affected by pre‐ and post mortem factors
Harish, G., Venkateshappa, C., Mahadevan, A., Pruthi, N., Bharath, M. M. S., & Shankar, S. K. (2012) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2012.01285.x · Cited by 47
Mendes‐Oliveira, J., Campos, F. L., Videira, R. A., & Baltazar, G. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.04.016 · Cited by 47
Health-Related Quality of Life Subdomains in Patients with Parkinson’s Disease: The Role of Gender
Ophey, A., Eggers, C., Dano, R., Timmermann, L., & Kalbe, E. (2018) · Parkinson s Disease · doi:10.1155/2018/6532320 · Cited by 47
Astrocytes Mediate Protective Actions of Estrogenic Compounds after Traumatic Brain Injury
Martín-Jiménez, C., Gaitán-Vaca, D. M., Mazo, N. A., Echeverría, V., Ashraf, G. M., González, J., Sahebkar, A., García‐Segura, L. M., & Barreto, G. E. (2018) · Neuroendocrinology · doi:10.1159/000495078 · Cited by 47
Clinical Heterogeneity Among LRRK2 Variants in Parkinson's Disease: A Meta-Analysis
Li, S., Zhang, Y., Pan, H., et al. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00283 · Cited by 44
González‐Giraldo, Y., Forero, D. A., Echeverría, V., García‐Segura, L. M., & Barreto, G. E. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.02.017 · Cited by 43
Goekoop, R., Barkhof, F., Duschek, E. J. J., Netelenbos, J. C., Knol, D. L., Scheltens, P., & Rombouts, S. A. R. B. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300956 · Cited by 41
Jaber, S. M., Bordt, E. A., Bhatt, N. M., Lewis, D. M., Gerecht, S., Fiskum, G., & Polster, B. M. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2017.09.003 · Cited by 40
What predicts falls in Parkinson disease? Observations from the Parkinson's Foundation registry
Parashos, S. A., Bloem, B. R., Browner, N., Giladi, N., Gurevich, T., Hausdorff, J. M., He, Y., Lyons, K. E., Mari, Z. K., Morgan, J. C., et al. (2018) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000000461 · Cited by 39
Age‐ and sex‐related heterogeneity in prodromal Parkinson's disease
Heinzel, S., Kasten, M., Behnke, S., Vollstedt, E., Klein, C., Hagenah, J. M., Pausch, C., Heilmann, R., Brockmann, K., Suenkel, U., et al. (2018) · Movement Disorders · doi:10.1002/mds.27349 · Cited by 37
Impact of gender and genetics on emotion processing in Parkinson's disease - A multimodal study
Heller, J., Mirzazade, S., Romanzetti, S., Habel, U., Derntl, B., Freitag, N. M., Schulz, J. B., Dogan, I., & Reetz, K. (2018) · NeuroImage Clinical · doi:10.1016/j.nicl.2018.01.034 · Cited by 37
Occupational stress and risk for Parkinson's disease: A nationwide cohort study
Sieurin, J., Andel, R., Tillander, A., Valdés, E. G., Pedersen, N. L., & Wirdefeldt, K. (2018) · Movement Disorders · doi:10.1002/mds.27439 · Cited by 35
Jacobsen, D. E., Melis, R. J. F., Verhaar, H. J. J., & Rikkert, M. G. M. O. (2011) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2011.05.005 · Cited by 33
Centrally Synthesized Estradiol Is a Potent Anti-Inflammatory in the Injured Zebra Finch Brain
Pedersen, A. L., Nelson, L. H., & Saldanha, C. J. (2016) · Endocrinology · doi:10.1210/en.2015-1991 · Cited by 33
Ou, R., Liu, H., Hou, Y., Song, W., Cao, B., Wei, Q., Yuan, X., Chen, Y., Zhao, B., & Shang, H. (2018) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2018.03.020 · Cited by 33
Sex differences in the progressive model of parkinsonism induced by reserpine in rats
Bispo, J. M. M., Melo, J. E. C., de Gois, A. M., Leal, P. C., Lins, L. C. R. F., Souza, M. F., Medeiros, K. A. A. L., Ribeiro, A. M., Silva, R. H., Marchioro, M., et al. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.01.041 · Cited by 33
Differential regulation of estrogen in iron metabolism in astrocytes and neurons
Xu, M., Tan, X., Li, N., Wu, H., Wang, Y., Xie, J., & Wang, J. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27188 · Cited by 32
Quality of life in a German cohort of Parkinson’s patients assessed with three different measures
Balzer‐Geldsetzer, M., Klotsche, J., Dodel, R. C., & Riedel, O. (2018) · Journal of Neurology · doi:10.1007/s00415-018-9047-9 · Cited by 32
Vukajlović, J. M., Drakulić, D., Pejić, S., Petković, M., Ilic, T. V., Miljković, M., Stefanović, A., Prostran, M. S., & Stojanov, M. (2017) · International Journal of Neuroscience · doi:10.1080/00207454.2017.1403916 · Cited by 31
Antidepressant and antipsychotic prescribing in primary care for people with dementia.
Drummond, N., McCleary, L., Freiheit, E., Molnar, F., Dalziel, W. B., Cohen, C. A., Turner, D., Miyagishima, R., & Silvius, J. L. (2018) · Europe PMC (PubMed Central) · Cited by 31
Korol, D. L., & Wang, W. (2017) · Physiology & Behavior · doi:10.1016/j.physbeh.2017.11.022 · Cited by 30
Low body mass index and life prognosis in Parkinson's disease
Park, K., Oeda, T., Kohsaka, M., Tomita, S., Umemura, A., & Sawada, H. (2018) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2018.05.011 · Cited by 29
dos Santos, E. U. D., Sampaio, T. F., dos Santos, A. D. T., Leite, F. C. B., da Silva, R. C., Crovella, S., Asano, A. G., Asano, N. M. J., & de Souza, P. R. E. (2018) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.13031 · Cited by 28
The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease
Frau, R., Savoia, P., Fanni, S., Fiorentini, C., Fidalgo, C., Tronci, E., Stancampiano, R., Meloni, M., Cannas, A., Marrosu, F., et al. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.01.012 · Cited by 27
Wang, J., Yu, R., Han, Q.-Q., Huang, H., Wang, Y.-L., Li, H., Wang, H., Chen, X., Ma, S., & Yu, J. M. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.07.017 · Cited by 27
Kon, T., Ueno, T., Haga, R., & Tomiyama, M. (2018) · Brain and Behavior · doi:10.1002/brb3.1036 · Cited by 26
Waters, E. M., Mazid, S., Dodos, M., Puri, R., Janssen, W. G. M., Morrison, J. H., McEwen, B. S., & Milner, T. A. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.09.025 · Cited by 26
Male-Specific Alleviation of Iron-Induced Striatal Injury by Inhibition of Autophagy
Wang, L., Yokoyama, K. K., Chen, T., Hsiao, H.-W., Chiang, P.-C., Hsieh, Y., Lo, S. J., & Hsu, C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0131224 · Cited by 25
Teschke, K., Marion, S. A., Tsui, J. K. C., Shen, H., Rugbjerg, K., & Harris, M. A. (2013) · American Journal of Industrial Medicine · doi:10.1002/ajim.22272 · Cited by 25
Costa, G., Porceddu, P. F., Serra, M., Casu, M. A., Schiano, V., Napolitano, F., Pinna, A., Usiello, A., & Morelli, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071556 · Cited by 24
Lee, Y., Park, Y.-H., Lee, J. J., Sohn, Y. H., Lee, J., & Lee, P. H. (2018) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2018.03.023 · Cited by 23
Association between sex, systemic iron variation and probability of Parkinson's disease
Mariani, S., Ventriglia, M. C., Simonelli, I., Bucossi, S., Siotto, M., Donno, S., Vernieri, F., & Squitti, R. (2015) · International Journal of Neuroscience · doi:10.3109/00207454.2015.1020113 · Cited by 22
Escames, G., Díaz-Casado, M. E., Doerrier, C., Luna‐Sánchez, M., López, L. C., & Acuña-Castroviejo, D. (2013) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2013-0026 · Cited by 21
Motor subtypes and other risk factors associated with drooling in Parkinson's disease patients
Mao, C., Xiong, Y.-T., Wang, F., Yang, Y., Yuan, W., Zhu, C. W., Chen, J.-P., & Liu, C. (2018) · Acta Neurologica Scandinavica · doi:10.1111/ane.12893 · Cited by 21
Liu, L., Xiong, N., Zhang, P., Chen, C., Huang, J., Zhang, G., Xu, X., Shen, Y., Lin, Z., & Wang, T. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135425 · Cited by 19
Chamniansawat, S., & Sawatdiyaphanon, C. (2018) · International Journal of Toxicology · doi:10.1177/1091581818761653 · Cited by 16
Rhes Counteracts Dopamine Neuron Degeneration and Neuroinflammation Depending on Gender and Age
Costa, G., Pinna, A., Porceddu, P. F., Casu, M. A., Maio, A. D., Napolitano, F., Usiello, A., & Morelli, M. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00163 · Cited by 10
Antipsychotic Drug Dispensing in Older Adults With Parkinsonism
Marras, C., Austin, P. C., Bronskill, S. E., Diong, C. C., & Rochon, P. A. (2018) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2018.08.003 · Cited by 10
Cited by
Incidence of Parkinson disease in North America
Willis, A. W., Roberts, E., Beck, J. C., Fiske, B., Ross, W., Savica, R., Van Den Eeden, S. K., Tanner, C. M., Marras, C., on behalf of the Parkinson’s Foundation P4 Group, et al. (2022) · npj Parkinson's Disease · doi:10.1038/s41531-022-00410-y · Cited by 341
Dentamaro, V., Impedovo, D., Musti, L., Pirlo, G., & Taurisano, P. (2024) · Scientific Reports · doi:10.1038/s41598-024-70165-4 · Cited by 116
Kawahata, I., & Fukunaga, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113779 · Cited by 71
Amin, R., Quispe, C., Docea, A. O., Ydyrys, A., Kulbayeva, M., Durna Daştan, S., Calina, D., & Sharifi-Rad, J. (2022) · Neurochemistry International · doi:10.1016/j.neuint.2022.105376 · Cited by 74
Tauroursodeoxycholic acid (TUDCA) is neuroprotective in a chronic mouse model of Parkinson’s disease
Cuevas, E., Burks, S., Raymick, J., Robinson, B., Gómez-Crisóstomo, N. P., Escudero-Lourdes, C., Lopez, A. G. G., Chigurupati, S., Hanig, J., Ferguson, S. A., et al. (2022) · Nutritional Neuroscience · doi:10.1080/1028415x.2020.1859729 · Cited by 57
Metadata
- Authors
- Cerri, S., Mus, L., & Blandini, F.
- Venue
- Journal of Parkinson’s Disease
- Publisher
- SAGE Publications
- Published
- 2019-07-04
- Volume
- 9
- Issue
- 3
- Pages
- 501-515
- ISSN
- 1877-7171 (ISSN-L)
- 1877-718X
- OpenAlex
- W2953791151
- Cited by
- 800
- References
- 123
- FWCI
- 29.29
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.